Revelle Aesthetics
Dr. Schaison is a CEO, CCO and Global President, in consumer healthcare, consumer goods & retail sectors (Asia, South America & Europe) with experience running a $2.5B+ business growing 17% a year (Allergan), acquiring/integrating a +$2B organization, and successfully leading global organizations. His communication/interpersonal skills & ability to work effectively with boards/senior executives and build/lead high-performance teams has informed all his work.
Hired as CEO of Syneron-Candela NA to take the publicly-traded company (ELOS) private, Dr. Schaison sold the company to Private Equity firm Apax in July 2017. Earlier, as Allergan President, US Aesthetic & Dermatology, Dr. Schaison led the Facial Aesthetic, Plastic and MedDerm/Skin Medical Business Unit Presidents. He secured market leadership for Botox and led the acquisition of Kythera.
Previously, Dr. Schaison was President, Clarins Worldwide Travel Retail & Regional President, LATAM and MEA, CEO of Aesthetic Factors, and VP of Global Skin Care for Johnson & Johnson. He sits on the Board of Directors for many companies, including SENTE, Sientra, Dyve Biosciences, and the Galien Foundation.
Dr. Schaison earned an MBA from the Hautes Etudes Commerciales, and a Doctorate in Pharmacy from the University of Paris V.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Revelle Aesthetics
Revelle Aesthetics features a team of the brightest and most passionate minds in the medical device and aesthetics industries.